Stocktoria

Esperion Therapeutics, Inc. ESPR

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2013-06-24 · LEI

Esperion Therapeutics, Inc. statistics & valuation

Market cap$816.9M
P / S2.0×
Net margin-5.6%
FCF margin-3.2%
Return on capital36.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-65.50% -63.10% -343.00% -309.60% -179.90% -15.60% -5.60% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-62.80% -53.30% -289.00% -237.80% -133.70% 16.40% 15.00% 2016201720182019202020212022202320242025
Return on equity (%)
-32.80% -68.20% -255.10% -487.00% 2016201720182019202020212022202320242025
Shares outstanding
22.6M 26.3M 26.8M 27.5M 27.5M 28.9M 66.4M 103.1M 187.2M 207.9M 2016201720182019202020212022202320242025
Net debt ($)
-$37.1M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-30.60% -60.10% -140.70% -45.30% -40.60% -70.50% -94.20% -101.70% -15.00% -4.90% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-48.10% -37.80% -336.30% -231.60% -116.50% -7.20% -3.20% 2016201720182019202020212022202320242025
Debt / equity (×)
0.00× 2016201720182019202020212022202320242025
EPS ($)
-$3.59 -$5.23 -$9.31 -$3.52 -$2.03 -$0.28 -$0.11 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin15.0%16.4%-133.7%-237.8%-289.0%-53.3%-62.8%———
Net margin-5.6%-15.6%-179.9%-309.6%-343.0%-63.1%-65.5%———
FCF margin-3.2%-7.2%-116.5%-231.6%-336.3%-37.8%-48.1%———
Return on assets-4.9%-15.0%-101.7%-94.2%-70.5%-40.6%-45.3%-140.7%-60.1%-30.6%
Return on equity7.5%13.3%46.0%72.2%136.6%149.3%-487.0%-255.1%-68.2%-32.8%
Debt / equity—————————0.00×
Current ratio1.541.371.292.674.483.683.202.226.1513.70

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.